Novavax Inc (WBO:NVAX)
€ 9.276 -0.09 (-0.96%) Market Cap: 1.49 Bil Enterprise Value: 734.28 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 47/100

Novavax Inc at Robert W Baird Global Healthcare Conference Transcript

Sep 13, 2022 / 12:30PM GMT
Unidentified Analyst

Hey, good morning, everyone, and welcome to Baird's Annual Healthcare Conference. I'm really pleased to be kicking off the conference with Novavax. And with me today, I have Gregory Glenn, President of R&D; and John Trizzino, Chief Commercial Officer and Chief Business Officer. Greg and John, thanks so much for joining us today.

John Joseph Trizzino
Novavax, Inc. - Executive VP and Chief Business & Commercial Officer

Great to be here as well, thank you.

Questions & Answers

Unidentified Analyst

So to begin, could you provide an overview of Novavax? And I think most people here would probably be familiar with Novavax now but also kind of recent update on progress to date.

John Joseph Trizzino
Novavax, Inc. - Executive VP and Chief Business & Commercial Officer

Yes. So maybe I'll just kind of kick things off with where we are with our activities since the beginning of the pandemic as it's been quite a venture, chatted a little bit briefly this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot